Inventor · disambiguated record
Richard Wyatt
Also filed as: WYATT RICHARD · WYATT RICHARD T
19 granted patents·5 pending applications·159 citations·filing 1992–2018
93Inventor score
Files withINT AIDS VACCINE INITIATIVE5DANA FARBER CANCER INST INC3UNIV COLUMBIA3US HEALTH3KWONG PETER2
Top patents by PatentIndex Score
24 records- 0193US8637036B2Neutralizing antibodies to HIV-1 and their useMASCOLA JOHN R·Filed 2012·Granted Jan 28, 2014·22 cites·23 claims
- 0293US6911205B2Stabilized soluble glycoprotein trimersUNIV COLUMBIA·Filed 2002·Granted Jun 28, 2005·49 cites·18 claims
- 0392US7429653B2Stabilized soluble glycoprotein trimersDANA FARBER CANCER INST INC·Filed 2005·Granted Sep 30, 2008·13 cites·10 claims
- 0485US9738703B2Neutralizing antibodies to HIV-1 and their useUS HEALTH·Filed 2015·Granted Aug 22, 2017·2 cites·21 claims
- 0584US9175070B2Neutralizing antibodies to HIV-1 and their useMASCOLA JOHN R·Filed 2010·Granted Nov 3, 2015·4 cites·7 claims
- 0680US10035845B2Neutralizing antibodies to HIV-1 and their useUS HEALTH·Filed 2017·Granted Jul 31, 2018·2 cites·21 claims
- 0776US8268323B2Conformationally stabilized HIV envelope immunogensKWONG PETER·Filed 2011·Granted Sep 18, 2012·2 cites·20 claims
- 0874US10058604B2Soluble HIV-1 envelope glycoprotein trimersINT AIDS VACCINE INITIATIVE·Filed 2014·Granted Aug 28, 2018·3 cites·17 claims
- 0973US6908617B1Glycosylated modified primate lentivirus envelope polypeptidesUNIV COLUMBIA·Filed 1998·Granted Jun 21, 2005·24 cites·13 claims
- 1065US8044185B2Conformationally stabilized HIV envelope immunogens and triggering HIV-I envelope to reveal cryptic V3-loop epitopesUS HEALTH·Filed 2006·Granted Oct 25, 2011·0 cites·24 claims
- 1164US7276579B2Immunogenic proteoliposomes, and uses thereofDANA FARBER CANCER INST INC·Filed 2001·Granted Oct 2, 2007·1 cites·9 claims
- 1261US7048929B1Stabilized primate lentivirus envelope glycoproteinsUNIV COLUMBIA·Filed 1998·Granted May 23, 2006·16 cites·15 claims
- 1357US8715686B2Conformationally stabilized HIV envelope immunogensKWONG PETER·Filed 2012·Granted May 6, 2014·0 cites·20 claims
- 1453US7741024B2Immunogenic proteoliposomes, and uses thereofDANA FARBER CANCER INST INC·Filed 2007·Granted Jun 22, 2010·0 cites·8 claims
- 1553US5817316AImmunogenic peptides, antibodies and uses thereof relating to CD4 receptor bindingDANA FARBER CANCER INSTISTUTE·Filed 1992·Granted Oct 6, 1998·21 cites·11 claims
- 1652US2008267989A1Hiv Gp-41-Membrane Proximal Region Arrayed On Hepatitis B Surface Antigen Particles as Novel AntigensUS GOV HEALTH & HUMAN SERV·Filed 2006·Application pending·0 cites
- 1747US9931394B2Soluble HIV-1 envelope glycoprotein trimersINT AIDS VACCINE INITIATIVE·Filed 2016·Granted Apr 3, 2018·0 cites·18 claims
- 1847US2002173446A1Compounds which bind to the central cavity between HIV-1 gp120 and CD4 and uses thereofFiled 2001·Application pending·0 cites
- 1945US10870683B2N-glycan deleted HIV-1 envelope glycoprotein trimersINT AIDS VACCINE INITIATIVE·Filed 2018·Granted Dec 22, 2020·0 cites·14 claims
- 2045US2010068217A1Epitope-transplant scaffolds and their useKWONG PETER D·Filed 2007·Application pending·0 cites
- 2138US10174292B2Soluble HIV-1 envelope glycoprotein trimersINT AIDS VACCINE INITIATIVE·Filed 2016·Granted Jan 8, 2019·0 cites·15 claims
- 2237US8147840B2Human immunodeficiency virus (HIV) immunization strategies employing conformationally-stabilized, surface-occluded peptides comprising a gp41 2F5 epitope in association with lipidOFEK GILAD·Filed 2005·Granted Apr 3, 2012·0 cites·7 claims
- 2332US2016362478A1Cd4-mimetic small molecules sensitize human immunodeficiency virus to vaccine-elicited antibodiesMADANI NAVID·Filed 2015·Application pending·0 cites
- 2431US2016033532A1Mammalian protein co-recognition by broadly neutralizing antibodies as modified immunogens for re-elicitationINT AIDS VACCINE INITIATIVE·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Richard Wyatt files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →